Profil
Jonathan Weissman is the founder of KSQ Therapeutics, Inc., founded in 2015.
Dr. Weissman is also the founder of Chroma Medicine, Inc.,DEM BioPharma, Inc...
Dr. Weissman currently works as a Venture Advisor at 5AM Venture Management LLC, a position held since 2018.
Dr. Weissman earned a doctorate from the Massachusetts Institute of Technology and completed undergraduate studies at Harvard College.
Postes actifs de Jonathan Weissman
| Sociétés | Poste | Début |
|---|---|---|
5AM Venture Management LLC
5AM Venture Management LLC Investment ManagersFinance 5AM Ventures invests in companies located in the US with an investment size ranging from $20 to $30 million. The firm targets companies operating in the fields of life sciences. It provides financing for early stage and corporate spin-out capital requirements and also makes co-investments. | Consultant / Advisor | 01/07/2018 |
DEM BioPharma, Inc.
DEM BioPharma, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biopharmaceutical company that manufactures cancer therapeutics | Fondateur | - |
Anciens postes connus de Jonathan Weissman
| Sociétés | Poste | Fin |
|---|---|---|
Chroma Medicine, Inc.
Chroma Medicine, Inc. Pharmaceuticals: MajorHealth Technology Manufactures genomic medicines | Fondateur | - |
KSQ Therapeutics, Inc.
KSQ Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops therapeutics for cancer | Fondateur | - |
Formation de Jonathan Weissman
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Massachusetts Institute of Technology
Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
5AM Venture Management LLC
5AM Venture Management LLC Investment ManagersFinance 5AM Ventures invests in companies located in the US with an investment size ranging from $20 to $30 million. The firm targets companies operating in the fields of life sciences. It provides financing for early stage and corporate spin-out capital requirements and also makes co-investments. | Finance |
Harvard College
Harvard College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
KSQ Therapeutics, Inc.
KSQ Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops therapeutics for cancer | Health Technology |
Chroma Medicine, Inc.
Chroma Medicine, Inc. Pharmaceuticals: MajorHealth Technology Manufactures genomic medicines | Health Technology |
DEM BioPharma, Inc.
DEM BioPharma, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biopharmaceutical company that manufactures cancer therapeutics | Commercial Services |
















